SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia.
van der Werf I, Wojtuszkiewicz A, Yao H, Sciarrillo R, Meggendorfer M, Hutter S, Walter W, Janssen J, Kern W, Haferlach C, Haferlach T, Jansen G, Kaspers GJL, Groen R, Ossenkoppele G, Cloos J.
van der Werf I, et al. Among authors: wojtuszkiewicz a.
Leukemia. 2021 Sep;35(9):2698-2702. doi: 10.1038/s41375-021-01273-7. Epub 2021 May 17.
Leukemia. 2021.
PMID: 34002025
Free PMC article.
No abstract available.